BlackRock’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-5,763,585
| Closed | -$116M | – | 5910 |
|
|
2021
Q3 | $116M | Sell |
5,763,585
-11,949
| -0.2% | -$330K | ﹤0.01% | 2117 |
|
|
2021
Q2 | $216M | Sell |
5,775,534
-341,632
| -6% | -$10.5M | 0.01% | 1707 |
|
|
2021
Q1 | $156M | Buy |
6,117,166
+82,437
| +1% | +$2.11M | ﹤0.01% | 1894 |
|
|
2020
Q4 | $133M | Buy |
6,034,729
+235,875
| +4% | +$5.2M | ﹤0.01% | 1898 |
|
|
2020
Q3 | $104M | Sell |
5,798,854
-135,426
| -2% | -$2.8M | ﹤0.01% | 1857 |
|
|
2020
Q2 | $151M | Buy |
5,934,280
+875,733
| +17% | +$18.9M | 0.01% | 1563 |
|
|
2020
Q1 | $92.9M | Buy |
5,058,547
+625,457
| +14% | +$12.2M | ﹤0.01% | 1690 |
|
|
2019
Q4 | $97.7M | Buy |
4,433,090
+66,597
| +2% | +$1.34M | ﹤0.01% | 1974 |
|
|
2019
Q3 | $62.7M | Buy |
4,366,493
+94,433
| +2% | +$1.35M | ﹤0.01% | 2155 |
|
|
2019
Q2 | $67.3M | Buy |
4,272,060
+8,441
| +0.2% | +$115K | ﹤0.01% | 2154 |
|
|
2019
Q1 | $62.5M | Sell |
4,263,619
-67,609
| -2% | -$777K | ﹤0.01% | 2155 |
|
|
2018
Q4 | $46.3M | Buy |
4,331,228
+1,364,155
| +46% | +$17.9M | ﹤0.01% | 2284 |
|
|
2018
Q3 | $45.3M | Buy |
2,967,073
+359,178
| +14% | +$5.23M | ﹤0.01% | 2430 |
|
|
2018
Q2 | $31.9M | Buy |
2,607,895
+2,330,402
| +840% | +$29.3M | ﹤0.01% | 2612 |
|
|
2018
Q1 | $2.65M | Buy |
277,493
+160,172
| +137% | +$1.73M | ﹤0.01% | 3603 |
|
|
2017
Q4 | $1.06M | Buy |
117,321
+3,925
| +3% | +$28.9K | ﹤0.01% | 3886 |
|
|
2017
Q3 | $652K | Sell |
113,396
-1,669
| -1% | -$6.07K | ﹤0.01% | 4008 |
|
|
2017
Q2 | $364K | Sell |
115,065
-15,388
| -12% | -$48.6K | ﹤0.01% | 4102 |
|
|
2017
Q1 | $443K | Buy |
130,453
+128,196
| +5,680% | +$361K | ﹤0.01% | 3995 |
|
|
2016
Q4 | $7K | Sell |
2,257
-1,617
| -42% | -$5.75K | ﹤0.01% | 3473 |
|
|
2016
Q3 | $23K | Hold |
3,874
| – | – | ﹤0.01% | 3255 |
|
|
2016
Q2 | $12K | Buy |
3,874
+3,658
| +1,694% | +$15K | ﹤0.01% | 3389 |
|
|
2016
Q1 | $1K | Buy |
+216
| New | +$1.36K | ﹤0.01% | 3590 |
|
|
2014
Q2 | – | Sell |
-12,600
| Closed | -$356K | – | 3252 |
|
|
2014
Q1 | $356K | Buy |
+12,600
| New | +$468K | ﹤0.01% | 1398 |
|
Other funds holding DRNA
BlackRock's DRNA Position: Q4 2021 in Review
BlackRock sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 5,763,585 shares — an estimated $116M sold.
BlackRock first reported a position in DRNA in Q1 2014 and held it in 24 quarters. The position peaked at $216M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- BlackRock reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- BlackRock sold 5,763,585 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $116M.
- BlackRock first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2014 and held it in 24 quarters.
- BlackRock's Dicerna Pharmaceuticals, Inc. position peaked at $216M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on BlackRock's 13F filing for Q4 2021, filed 10 Feb 2022.